
Biopharma & Healthcare Solutions | Grifols
Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the …
Soluciones Biofarmacéuticas y Sanitarias | Grifols
Descubre las innovadoras soluciones biofarmacéuticas y sanitarias integrales de Grifols centradas en el paciente.
Poland | Grifols Polska | Pharma Solutions
Explore Grifols Poland, a leader in biotechnology and healthcare, dedicated to improving patient lives through innovative therapies and high-quality services.
Company | Grifols
Grifols is a global healthcare company that has enhanced the health and well-being of people around the world.
Ireland - Grifols Worldwide Operations | Grifols
Overview of Grifols' operations in Ireland and country-specific statutory disclosures, including regulatory reporting and compliance information.
Careers with Purpose | Join Grifols for a Meaningful Future
Join Grifols to create a lasting impact with your career. Explore opportunities that allow you to contribute to life-saving solutions and innovate for a healthier future.
What we do | Grifols
Grifols is also a leader in transfusion medicine, helping ensure the safety of the world’s blood supply. In addition, we provide biological materials, including plasma, for life-science research and further …
Our history - Grifols.com
We trace our roots back to 1909 when Dr. Josep Antoni Grifols i Roig founded the first analysis laboratory in Barcelona: Instituto Central de Análisis Clínicos, Bacteriológicos y Químicos.
Grifols prepares IPO of its US Biopharma business
Mar 24, 2026 · The sale of a minority stake of its U.S. Biopharma business by means of an initial public offering (IPO) would raise capital to strengthen the Group’s balance sheet, reduce debt and support …
Contact Grifols | Reach Out for Inquiries and Support
Contact Grifols for inquiries and support. Our team is here to assist you with information and resources tailored to your needs.